Basic (delayed 15 min.) | Subscribe for real time Add to portfolio 3:59pm ET 10.84 1.28 (13.37%) Day's Range: 9.91 - 11.15 Day's Volume: 175,670 Avg. Volume: 0 Bid 10.60 Prev. Close 9.561 Yield N/A P/E -25.09 EPS -0.43 Div/Shr 0.00 Ask 11.55 Open 10.13 Mkt Cap 206.86 52-wk range 3.15 - 9.77
Industry: N/A $7 Trades, NO FEE IRAS Get $100 Credit when you open an account with Harrisdirect*
Ranked #1 by J.D. POWER Join Harrisdirect Brown & Co Switch to $5 trades Sharebuilder Buy stocks for $4
Marshall Edwards Inc. Begins Trial of Phenoxodiol at Yale University School of Medicine for Women with Ovarian Cancer 10 Dec 2002, 08:07am ET (PR Newswire)
WebCast Alert: Investigational Cancer Drug Proves Safety; Enters Phase II Human Clinical Trials 7 Oct 2002, 07:45am ET (PR Newswire)
WebCast Alert: Investigational Cancer Drug Proves Safety; Enters Phase II Human Clinical Trials 2 Oct 2002, 12:04pm ET (PR Newswire) - - - - - MORE NVGN News »
NEW! Stock Research Tool Ask a question about a company, sector, or industry in plain english:
Example: Which 10 software companies have the highest sales? Learn more »
Message Board Add Board to My Finances
most recent posts on the NASDAQ:NVGN board.
Msg. # Subject Posted by Rating* Date
1245 Will rest a bit at 15 ahoy6 02 Jan 2003 12:45pm ET
1244 Andy, it's a bullet! I set stops and will move up IAMSAM $$$$ 02 Jan 2003 11:49am ET
1243 NVGN ... next target $12 !!! Waaaahoooo! eom andy20020 $$$$ 02 Jan 2003 11:23am ET
1242 Somethings wrong! VXN up over a point in this mark andy20020 $$$$ 02 Jan 2003 10:57am ET
1241 NVGN, ahoy6 02 Jan 2003 10:40am ET
- - - - - View NASDAQ:NVGN Board | Post a message on NASDAQ:NVGN
* Member Ratings (zero to five dollar signs) display a member's credibility on Raging Bull. They do not represent ratings of the individual messages. More about ratings
Intraday chart
View a free, streaming LiveChart »
Subscribe today for Real-time streaming charts or Log in if you are already a subscriber. - - - - -
have a good day...
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held